Company Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-23 pm EDT			5-day change	1st Jan Change
52.54 ^USD	-0.91%		-1.43%	-6.50%

Jun. 04	Exact Sciences Corporation, Q1 2025 Earnings Call, May 01, 2025
Jun. 03	Exact Sciences Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 08:40 AM

Business description: Exact Sciences Corporation

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Companyâs products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Companyâs flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patientâs breast tumor tissue.

Number of employees: 6,950

Sales by Activity: Exact Sciences Corporation

Fiscal Period: December	2020	2021	2022	2023	2024
Biotechnology (Startups)	1.49B	1.77B	2.08B	2.5B	2.76B

See all business segments

Geographical breakdown of sales: Exact Sciences Corporation

Fiscal Period: December	2020	2021	2022	2023	2024
United States	1.41B	1.66B	1.97B	2.35B	2.57B
Outside of United States	77.48M	110M	118M	153M	189M

See all geographic segments

Executive Committee: Exact Sciences Corporation

Manager	Title	Age	Since
Kevin Conroy CEO	Chief Executive Officer	59	2009-03-17
Aaron Bloomer DFI	Director of Finance/CFO	39	2024-04-14
Tomasz Beer CTO	Chief Tech/Sci/R&D Officer	-	2021-12-31
Frederick Baehner CTO	Chief Tech/Sci/R&D Officer	-	2018-12-31
Jorge Garces CTO	Chief Tech/Sci/R&D Officer	53	2021-03-31

See EXACT SCIENCES CORPORATION governance

Composition of the Board of Directors: Exact Sciences Corporation

Director	Title	Age	Since
Kevin Conroy CHM	Chairman	59	2014-03-20
Katherine Zanotti BRD	Director/Board Member	70	2009-04-28
Daniel Levangie BRD	Director/Board Member	75	2010-07-18
James Doyle BRD	Director/Board Member	79	2014-07-23
D. Coward BRD	Director/Board Member	60	2022-12-29
Shacey Petrovic BRD	Director/Board Member	52	2020-07-21
Paul Clancy BRD	Director/Board Member	63	2021-03-17
Michael Barber BRD	Director/Board Member	64	2024-06-12
Kim Popovits BRD	Director/Board Member	66	2025-01-01
Leslie Trigg BRD	Director/Board Member	54	2025-04-28

Composition of the Board of Directors

Shareholders: Exact Sciences Corporation

Name	Equities	%	Valuation
Fidelity Management & Research Co. LLC 14.92 %	27,722,623	14.92 %	1 560 M $
Capital Research & Management Co. (World Investors) 9.601 %	17,835,277	9.601 %	1 004 M $
Vanguard Fiduciary Trust Co. 9.495 %	17,637,674	9.495 %	993 M $
Wellington Trust Co., NA 6.73 %	12,501,316	6.73 %	704 M $
BlackRock Advisors LLC 5.066 %	9,410,336	5.066 %	530 M $

List of EXACT SCIENCES CORPORATION shareholders

Holdings: Exact Sciences Corporation

Name	Equities	%	Valuation
MDXHEALTH SA 4.93%	2,441,171	4.93%	5,138,665 $

Company details: Exact Sciences Corporation

EXACT Sciences Corp.

5505 Endeavor Lane

53719, Madison

+608 284 5700

http://www.exactsciences.com

address Exact Sciences Corporation(EXAS)

Group companies: Exact Sciences Corporation

Name	Category and Sector
GENOMIC HEALTH, INC.	Medical Specialties

See all subsidiaries

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
EXACT SCIENCES CORPORATION	-0.91%	-1.43%	+17.15%	+24.38%	9.91B
BGI GENOMICS CO., LTD.	+0.21%	-4.59%	+29.03%	-29.20%	2.55B
VERACYTE, INC.	+1.21%	+0.26%	+18.50%	+22.41%	2.09B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+1.73%	+2.62%	+225.93%	+21.38%	1.6B
SEEGENE, INC.	-1.63%	+1.68%	+59.62%	-1.92%	1.11B
CAREDX, INC	-0.47%	-0.63%	+34.78%	-21.14%	1.06B
IOVANCE BIOTHERAPEUTICS, INC.	-6.57%	-11.06%	-76.90%	-82.09%	618M
CURIOX BIOSYSTEMS CO., LTD	-0.73%	-16.42%	+32.17%	-	399M
MARAVAI LIFESCIENCES HOLDINGS, INC.	+2.43%	-2.31%	-70.86%	-92.45%	304M
3BILLION, INC.	-1.27%	-2.88%	-	-	178M
Average	+0.40%	-3.57%	+29.93%	-19.83%	1.98B
Weighted average by Cap.	-0.18%	-1.86%	+35.22%	+7.53%